A new self-administered treatment for severe eosinophilic asthma will be reimbursed by the Pharmaceutical Benefits Scheme from 1 June 2020.
World leaders in infection control and disease prevention convened online to discuss innovative infection control reform in hospitals and aged-care facilities.
A study published in the journal Thorax reveals that eight out of 10 passengers and crew who tested positive for the infection had no symptoms.
A review of more than 40 studies on coronavirus immunity suggests that SARS-CoV-2 could become the fifth seasonal coronavirus.
New research from the UK has debunked the claim that children are 'super-spreaders' of COVID-19, and the authors confirm it is now safe to send children back to school.
A UK study has revealed that age, male sex, obesity and underlying illness emerge as risk factors for severe COVID-19 or death.
Tens of thousands of Australians with chronic diseases are putting themselves at risk by missing vital visits to their GP.
Researchers found that pregnant women taking oral fluconazole appeared to have an increased risk of giving birth to a baby with muscle and bone malformations.
New insights into the molecular mechanisms driving mucus viscosity could help improve airway-clearing treatment options for patients with respiratory conditions.
National Drug Research Institute has released the first national update on the cost of opioids in 13 years — it's not a pretty picture.
A new study shows female university students are saving their calories for binge drinking.
The OUTBREAK project will use artificial intelligence to predict superbug outbreaks and model the best way to manage them before they reach the healthcare system.
Dr Angus Stock answers questions about Kawasaki Disease and the risk to children in Australia.
Repurposing existing medicines offers more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists.
The wafer has been designed to provide rapid and more predictable absorption of cannabis, improved bioavailability and the potential for faster therapeutic action.